Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference28 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018
2. Follow-up after primary therapy for endometrial cancer: a systematic review;Fung-Kee-Fung;Gynecol. Oncol.,2006
3. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study;Homesley;Gynecol. Oncol.,2009
4. Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study;Muggia;J. Clin. Oncol.,2002
5. Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study;Aghajanian;J. Clin. Oncol.,2011
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis;Journal of Gynecologic Oncology;2025
2. Cost effectiveness of immunotherapy combination therapies for endometrial cancer;Gynecologic Oncology Reports;2024-04
3. Lenvatinib plus pembrolizumab in the patients with advanced previously treated endometrial cancer: A cost‐effectiveness analysis in the United States and in China;Journal of Obstetrics and Gynaecology Research;2024-03-14
4. Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy;Gynecologic Oncology;2024-03
5. Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer;Journal of Gynecologic Oncology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3